The prognostic value of natural killer cell infiltration in resected pulmonary adenocarcinoma.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Journal of Thoracic and Cardiovascular Surgery

• Publication date

  2001-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1067/MTC.2001.113026PMID 11385371
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prognostic value of intratumoral natural killer cells in gastric carcinoma

  2000cited by this paper
• Immune cell infiltrates and prognosis in primary carcinoma of the lung.

  2000cited by this paper
• Infiltration of CD8+ T cells in non-small cell lung cancer is associated with dedifferentiation of cancer cells, but not with prognosis.

  2000cited by this paper
• Cancer statistics, 1997

  1997cited by this paper
• The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma

  1997cited by this paper
• Correlation between the lymphocytic infiltration of tumors and the proliferative activity of cancer cells from surgically treated esophageal carcinoma.

  1997cited by this paper
• Natural killer cells and cancer

  1996cited by this paper
• Early-appearing tumour-infiltrating natural killer cells play a crucial role in the generation of anti-tumour T lymphocytes.

  1995cited by this paper
• Lymphocyte infiltrates as a prognostic variable in female breast cancer.

  1992cited by this paper
• Bronchiolo-alveolar carcinoma: an analysis of survival predictors.

  1992cited by this paper
• Influence of PGE2- and cAMP-modulating agents on human glioblastoma cell killing by interleukin-2-activated lymphocytes.

  1990cited by this paper
• Immunohistochemical study of natural killer cells in tumor-infiltrating lymphocytes of primary intracranial germinomas.

  1990cited by this paper
• Morphometric and morphologic evaluations in stage III non‐small cell lung cancers. Prognostic significance of quantitative assessment of infiltrating lymphoid cells

  1989cited by this paper
• Prognosis and survival in resected lung carcinoma based on the new international staging system.

  1988cited by this paper
• Lymphocytic infiltration and survival in rectal cancer.

  1986cited by this paper
• Prognostic factors in surgically resected limited-stage, nonsmall cell carcinoma of the lung

  1984cited by this paper
• A cell surface marker for neural crest and placodal cells: further evolution in peripheral and central nervous system.

  1984cited by this paper
• Gastric carcinoma with lymphoid stroma: Correlation to reactive hyperplasia in regional lymph nodes and prognosis

  1983cited by this paper

• Natural killer cells in skin: a unique opportunity to better characterize the many facets of an overlooked secondary lymphoid organ

  2025cites this paper
• Advances in augmenting infiltration of active natural killer cells into pediatric and adult solid tumors

  2025cites this paper
• PU.1 upregulation is linked to improved prognosis in non-small cell lung cancer

  2025cites this paper
• A Rare Case of Long-Term Survival in Stage IIIB Lung Adenocarcinoma: an 9-Year Follow-Up

  2025cites this paper
• 3D Chemotaxis Chip for Investigating Natural Killer Cell Migration Mechanisms

  2025cites this paper
• Interim report on engineered NK cell trial in lung cancer refractory to immune checkpoint inhibitors

  2025cites this paper
• Immune signatures of patients with advanced non-small-cell lung cancer for efficacy prediction after immunotherapy

  2024cites this paper
• Density of tumor-infiltrating NK and Treg cells is associated with 5 years progression-free and overall survival in resected lung adenocarcinoma.

  2024cites this paper
• Engineering immune response to regulate cardiovascular disease and cancer.

  2024cites this paper
• BET inhibitors drive Natural Killer activation in non-small cell lung cancer via BRD4 and SMAD3

  2024cites this paper
• Anti-PD-1 therapy reverses TIGIT+CD226+NK depletion in immunotherapy resistance of hepatocellular carcinoma through PVR/TIGIT pathway.

  2024cites this paper
• Characteristics of the immune microenvironment and their clinical significance in lung adenocarcinoma patients with different ALK fusion variants

  2024cites this paper
• Natural Killer Cells in Cancers of Respiratory System and Their Applications in Therapeutic Approaches

  2024cites this paper
• Risks of malignancies related to disease-modifying antirheumatic drugs in rheumatoid arthritis: a pharmacovigilance analysis using the FAERS database

  2024cites this paper
• Current literature review on the tumor immune micro-environment, its heterogeneity and future perspectives in treatment of advanced non-small cell lung cancer

  2023cites this paper
• Natural killer cells and type 1 innate lymphoid cells in cancer.

  2023cites this paper
• Cannabinoid receptor 2 plays a pro-tumorigenic role in non-small cell lung cancer by limiting anti-tumor activity of CD8+ T and NK cells

  2023cites this paper
• Current status and future perspective of natural killer cell therapy for cancer

  2023cites this paper
• CD155 and its receptors in cancer immune escape and immunotherapy.

  2023cites this paper
• NK cell activity and methylated HOXA9 ctDNA as prognostic biomarkers in patients with non-small cell lung cancer treated with PD-1/PD-L1 inhibitors

  2023cites this paper
• Myeloperoxidase promotes a tumorigenic microenvironment in non-small cell lung cancer

  2023cites this paper
• Natural Killer Cells in Chronic Lymphocytic Leukemia: Functional Impairment and Therapeutic Potential

  2022cites this paper
• Immune Checkpoint Blockade: A Strategy to Unleash the Potential of Natural Killer Cells in the Anti-Cancer Therapy

  2022cites this paper
• KIR-HLA gene diversities and susceptibility to lung cancer

  2022cites this paper
• Underlying mechanisms of evasion from NK cells as rationale for improvement of NK cell-based immunotherapies

  2022cites this paper
• The HIV Latency Reversal Agent HODHBt Enhances NK Cell Effector and Memory-Like Functions by Increasing Interleukin-15-Mediated STAT Activation

  2022cites this paper
• The Combination of Radiotherapy and Complement C3a Inhibition Potentiates Natural Killer cell Functions Against Pancreatic Cancer

  2022cites this paper
• Recruited and Tissue-Resident Natural Killer Cells in the Lung During Infection and Cancer

  2022cites this paper
• Natural killer cell homing and trafficking in tissues and tumors: from biology to application

  2022cites this paper
• Role of the ITAM-Bearing Receptors Expressed by Natural Killer Cells in Cancer

  2022cites this paper
• Next Generation Natural Killer Cells for Cancer Immunotherapy

  2022cites this paper
• Overcoming Resistance to Checkpoint Inhibitors: Natural Killer Cells in Non-Small Cell Lung Cancer

  2022cites this paper
• Investigating the Clinico-Molecular and Immunological Evolution of Lung Adenocarcinoma Using Pseudotime Analysis

  2022cites this paper
• Multidimensional profiling depicts infiltrating immune cell heterogeneity in the tumor microenvironment of stage IA non‐small cell lung cancer

  2022cites this paper
• Methionine enkephalin (MENK) suppresses lung cancer by regulating the Bcl-2/Bax/caspase-3 signaling pathway and enhancing natural killer cell-driven tumor immunity.

  2021cites this paper
• Optimising NK cell metabolism to increase the efficacy of cancer immunotherapy

  2021cites this paper
• Targeting the ARNTL2 Gene as a Potential Strategy for Lung Adenocarcinoma

  2021cites this paper
• The emerging role of off-the-shelf engineered natural killer cells in targeted cancer immunotherapy

  2021cites this paper
• The HIV latency reversal agent HODHBt enhances NK Cell effector and memory-like functions by increasing IL-15 mediated-STAT activation

  2021cites this paper
• Histamine in cancer immunology and immunotherapy. Current status and new perspectives

  2021cites this paper
• Targeting Innate Immunity in Cancer Therapy

  2021cites this paper
• The Natural Killer–Dendritic Cell Immune Axis in Anti-Cancer Immunity and Immunotherapy

  2021cites this paper
• Exploring natural killer cell immunology as a therapeutic strategy in lung cancer

  2021cites this paper
• 3D Cancer Models: Depicting Cellular Crosstalk within the Tumour Microenvironment

  2021cites this paper
• Recombinant cancer nanovaccine for targeting tumor-associated macrophage and remodeling tumor microenvironment

  2021cites this paper
• Natural killer cell-based immunotherapy for lung cancer: Challenges and perspectives

  2021cites this paper
• Infiltration of NK and plasma cells is associated with a distinct immune subset in non‐small cell lung cancer

  2021cites this paper
• The Impact of NK Cell-Based Therapeutics for the Treatment of Lung Cancer for Biologics: Targets and Therapy

  2021cites this paper
• Natural killer cell engagers in cancer immunotherapy: Next generation of immuno‐oncology treatments

  2021cites this paper
• NK cells in the tumor microenvironment: Prognostic and theranostic impact. Recent advances and trends.

  2020cites this paper
• Prognostic Significance of Tumor-Infiltrating Natural Killer Cells in Solid Tumors: A Systematic Review and Meta-Analysis

  2020cites this paper
• Genome engineering of induced pluripotent stem cells to manufacture natural killer cell therapies

  2020cites this paper
• Current Perspectives, Challenges and Advances in Cell Based Therapies

  2020cites this paper
• Emerging Concepts on the NKG2D Receptor- NKG2D Ligand Axis in Health and Diseases

  2020cites this paper
• A human lung tumor microenvironment interactome identifies clinically relevant cell-type cross-talk

  2020cites this paper
• Characterization of patterns of immune cell infiltration in non-small cell lung cancer (NSCLC).

  2020cites this paper
• The Role of GSK-3 in Cancer Immunotherapy: GSK-3 Inhibitors as a New Frontier in Cancer Treatment

  2020cites this paper
• The current landscape of single-cell transcriptomics for cancer immunotherapy

  2020cites this paper
• Immune Modulation in Lung Cancer: Current Concepts and Future Strategies

  2020cites this paper
• NK cell infiltration is associated with improved overall survival in solid cancers: A systematic review and meta-analysis

  2020cites this paper
• iPSC-derived NK cells maintain high cytotoxicity and enhance in vivo tumor control in concert with T cells and anti–PD-1 therapy

  2020cites this paper
• NK Cells in the Tumor Microenvironment.

  2020cites this paper
• The NK cell–cancer cycle: advances and new challenges in NK cell–based immunotherapies

  2020cites this paper
• Functional recovery of natural killer cell activity by nanoparticle‐mediated delivery of transforming growth factor beta 2 small interfering RNA

  2019cites this paper
• NK cells and gammadelta T cells mediate resistance to NK cells and gammadelta T cells mediate resistance to polyomavirus-induced tumors polyomavirus-induced tumors

  2019influential citation
• SOCS-mediated immunomodulation of natural killer cells.

  2019cites this paper
• Overcoming Resistance to Natural Killer Cell Based Immunotherapies for Solid Tumors

  2019cites this paper
• NKG2D/NKG2-Ligand Pathway Offers New Opportunities in Cancer Treatment

  2019cites this paper
• NK Cells in the Human Lungs

  2019cites this paper
• Mast Cells and Natural Killer Cells—A Potentially Critical Interaction

  2019cites this paper
• Clinically-relevant cell type cross-talk identified from a human lung tumor microenvironment interactome

  2019cites this paper
• Enhanced adaptive immune responses in lung adenocarcinoma through natural killer cell stimulation

  2019cites this paper
• Advances in Molecular Mechanisms and Immunotherapy Involving the Immune Cell-Promoted Epithelial-to-Mesenchymal Transition in Lung Cancer

  2019cites this paper
• NK Cell Plasticity in Cancer

  2019cites this paper
• JAK-STAT Signaling: A Double-Edged Sword of Immune Regulation and Cancer Progression

  2019cites this paper
• Immune Cell Migration in Cancer and Immunotherapy

  2018cites this paper
• 5. SIGNIFICANCE OF IMMUNE CHECKPOINT PROTEINS IN EGFR-MUTANT NON-SMALL CELL LUNG CANCER

  2018influential citation
• Prognostic significance of immune cells in non-small cell lung cancer: meta-analysis

  2018cites this paper
• Caractérisation topologique d'interactions non-covalentes inter- et intramoléculaires

  2017cites this paper
• Patient’s Natural Killer Cells in the Era of Targeted Therapies: Role for Tumor Killers

  2017cites this paper
• Natural killer cells and anti-tumor immunity.

  2017cites this paper
• Immunomodulatory Magnetic Microspheres for Augmenting Tumor-Specific Infiltration of Natural Killer (NK) Cells.

  2017cites this paper
• Natural Killers Are Made Not Born: How to Exploit NK Cells in Lung Malignancies

  2017cites this paper
• NK Cells: Key to Success of DC-Based Cancer Vaccines?

  2017cites this paper
• Adoptive transfer of natural killer cells promotes the anti-tumor efficacy of T cells.

  2017cites this paper
• IL15 induces a potent antitumor activity in NK cells isolated from malignant pleural effusions and overcomes the inhibitory effect of pleural fluid

  2017cites this paper
• NK Cell Subsets in Health and Disease: New Developments

  2017cites this paper
• Mesenchymal stem cells overexpressing Sirt1 inhibit prostate cancer growth by recruiting natural killer cells and macrophages

  2016cites this paper
• The impact of cytomegalovirus infection on natural killer cell responses to vaccines

  2016cites this paper
• Image Analysis–based Assessment of PD-L1 and Tumor-Associated Immune Cells Density Supports Distinct Intratumoral Microenvironment Groups in Non–small Cell Lung Carcinoma Patients

  2016cites this paper
• Immune evasion in glioma

  2016cites this paper
• The Expanding Role of Natural Killer Cells in Type 1 Diabetes and Immunotherapy

  2016cites this paper
• Mesenchymal stem cells with Sirt1 overexpression suppress breast tumor growth via chemokine-dependent natural killer cells recruitment

  2016cites this paper
• Targeting the tumor microenvironment to improve natural killer cell-based immunotherapies: On being in the right place at the right time, with resilience

  2016cites this paper
• Immune Contexture, Immunoscore, and Malignant Cell Molecular Subgroups for Prognostic and Theranostic Classifications of Cancers.

  2016cites this paper
• Snake Venom synergized Cytotoxic Effect of Natural Killer Cells on NCI H358 Human Lung Cancer Cell Growth through Induction of Apoptosis

  2016cites this paper
• Investigating functions of tumor-infiltrating natural killer cells in genetically-engineered mouse models of non-small cell lung cancer

  2016cites this paper
• Less Can Be More for Gene Dose and Drug Sensitivity

  2015cites this paper
• The non-small cell lung cancer immune contexture. A major determinant of tumor characteristics and patient outcome.

  2015cites this paper
• CXCL10-induced migration of adoptively transferred human natural killer cells toward solid tumors causes regression of tumor growth in vivo

  2015cites this paper